Human carboxylesterase isozymes: catalytic properties and rational drug design.
暂无分享,去创建一个
[1] R. Mentlein,et al. Simultaneous purification and comparative characterization of six serine hydrolases from rat liver microsomes. , 1980, Archives of biochemistry and biophysics.
[2] A. Wahl,et al. Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug. , 2001, Bioconjugate chemistry.
[3] N. Bodor,et al. Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites. , 2002, Methods in molecular biology.
[4] E. Duysen,et al. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. , 2005, Biochemical pharmacology.
[5] W. Bosron,et al. Identification of microsomal rat liver carboxylesterases and their activity with retinyl palmitate. , 2002, European journal of biochemistry.
[6] P. Kuhn,et al. Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition. , 2003, Chemistry & biology.
[7] H. Chapman,et al. A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. , 1991, The Journal of biological chemistry.
[8] D. Murry,et al. Methylphenidate Is Stereoselectively Hydrolyzed by Human Carboxylesterase CES1A1 , 2004, Journal of Pharmacology and Experimental Therapeutics.
[9] Nico P E Vermeulen,et al. Enzyme-Catalyzed Activation of Anticancer Prodrugs , 2004, Pharmacological Reviews.
[10] Y. Rojanasakul,et al. Characterization of Mefenamic Acid-Guaiacol Ester: Stability and Transport Across Caco-2 Cell Monolayers , 2002, Pharmaceutical Research.
[11] C. Morton,et al. Proficient metabolism of irinotecan by a human intestinal carboxylesterase. , 2000, Cancer research.
[12] J Zhang,et al. Purification and Cloning of a Broad Substrate Specificity Human Liver Carboxylesterase That Catalyzes the Hydrolysis of Cocaine and Heroin* , 1997, The Journal of Biological Chemistry.
[13] M. Wierdl,et al. Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme. , 1998, Cancer research.
[14] P. Taylor,et al. Current progress on esterases: from molecular structure to function. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[15] Patrick J. Sinko,et al. Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds , 2004, Pharmaceutical Research.
[16] R. Mentlein,et al. A method for the estimation of esterase synthesis and degradation and its application to evaluate the influence of insulin and glucagon. , 1979, European journal of biochemistry.
[17] N. Bodor,et al. Physicochemical aspects of the enzymatic hydrolysis of carboxylic esters. , 2002, Die Pharmazie.
[18] D. Murry,et al. Hydrolysis of Capecitabine to 5′-Deoxy-5-fluorocytidine by Human Carboxylesterases and Inhibition by Loperamide , 2005, Journal of Pharmacology and Experimental Therapeutics.
[19] Hitoshi Sezaki,et al. Analysis of Drug Permeation Across Caco-2 Monolayer: Implication for Predicting In Vivo Drug Absorption , 1997, Pharmaceutical Research.
[20] W. Block,et al. Chromatographic study on the specificity of bis-p-nitrophenylphosphate in vivo. Identification of labelled proteins of rat liver after intravenous injection of bis-p-nitro[14C]phenylphosphate as carboxylesterases and amidases. , 1978, Biochimica et biophysica acta.
[21] W. Bosron,et al. Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. , 1994, Biochemical pharmacology.
[22] T. Imai,et al. IDENTIFICATION OF ESTERASES EXPRESSED IN CACO-2 CELLS AND EFFECTS OF THEIR HYDROLYZING ACTIVITY IN PREDICTING HUMAN INTESTINAL ABSORPTION , 2005, Drug Metabolism and Disposition.
[23] M. Merino Sanjuán,et al. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes. , 2002, International journal of pharmaceutics.
[24] A. Horita,et al. Species Differences in Stereoselective Hydrolase Activity in Intestinal Mucosa , 1998, Pharmaceutical Research.
[25] I. Björkhem,et al. Characterization of enzymes involved in formation of ethyl esters of long-chain fatty acids in humans. , 2001, Journal of lipid research.
[26] S. Tokudome,et al. IDENTIFICATION OF THE CYTOSOLIC CARBOXYLESTERASE CATALYZING THE 5′-DEOXY-5-FLUOROCYTIDINE FORMATION FROM CAPECITABINE IN HUMAN LIVER , 2004, Drug Metabolism and Disposition.
[27] M. Redinbo,et al. Structural insights into CPT-11 activation by mammalian carboxylesterases , 2002, Nature Structural Biology.
[28] B. Chaitman,et al. Myocardial cell damage by fatty acid ethyl esters. , 1996, Journal of cardiovascular pharmacology.
[29] W. Bosron,et al. Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. , 1999, The Journal of pharmacology and experimental therapeutics.
[30] O. Cummings,et al. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] T. Imai,et al. Evidence for the Involvement of a Pulmonary First-Pass Effect via Carboxylesterase in the Disposition of a Propranolol Ester Derivative after Intravenous Administration , 2003, Journal of Pharmacology and Experimental Therapeutics.
[32] B. Yan,et al. Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[33] G. Burton,et al. The Use of Esters as Prodrugs for Oral Delivery of β-Lactam Antibiotics , 2002 .
[34] J. Hochman,et al. Comparative studies of drug-metabolizing enzymes in dog, monkey, and human small intestines, and in Caco-2 cells. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[35] M. Tsuboi,et al. Species difference and characterization of intestinal esterase on the hydrolizing activity of ester-type drugs. , 1979, Japanese journal of pharmacology.
[36] B. Yan,et al. Rat Serum Carboxylesterase , 1995, The Journal of Biological Chemistry.
[37] K. Lackner,et al. Purification, cloning, and expression of a human enzyme with acyl coenzyme A: cholesterol acyltransferase activity, which is identical to liver carboxylesterase. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[38] B. Ma,et al. In vitro and in vivo evaluations of intestinal barriers for the zwitterion L-767,679 and its carboxyl ester prodrug L-775,318. Roles of efflux and metabolism. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[39] T. Hurley,et al. Lessons from a bacterial cocaine esterase , 2002, Nature Structural Biology.
[40] B. Chaitman,et al. Purification and characterization of human heart fatty acid ethyl ester synthase/carboxylesterase. , 1996, Journal of molecular and cellular cardiology.
[41] T. Langmann,et al. Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. , 1997, Biochemical and biophysical research communications.
[42] F. Fonnum,et al. A radiochemical assay method for carboxylesterase, and comparison of enzyme activity towards the substrates methyl [1-14C] butyrate and 4-nitrophenyl butyrate. , 1985, Biochemical pharmacology.
[43] R. Mentlein,et al. Subcellular localization of non-specific carboxylesterases, acylcarnitine hydrolase, monoacylglycerol lipase and palmitoyl-CoA hydrolase in rat liver. , 1988, Biochimica et biophysica acta.
[44] M. Dolan,et al. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2. , 2000, Cancer research.
[45] D. Kroetz,et al. Glycosylation-dependent activity of baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. , 1993, Biochemistry.
[46] T. Satoh,et al. Interindividual variation in carboxylesterase levels in human liver microsomes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[47] T. Imai,et al. Evaluation of Stereoselective Transdermal Transport and Concurrent Cutaneous Hydrolysis of Several Ester Prodrugs of Propranolol: Mechanism of Stereoselective Permeation , 1996, Pharmaceutical Research.
[48] Teruko Imai,et al. Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine , 2006, Drug Metabolism and Disposition.
[49] G. Amidon,et al. The Site-Specific Transport and Metabolism of Tacrolimus in Rat Small Intestine , 2003, Journal of Pharmacology and Experimental Therapeutics.
[50] Y. Sugiyama,et al. A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug. , 2000, The Journal of pharmacology and experimental therapeutics.
[51] K. Chiba,et al. cDNA cloning, characterization and stable expression of novel human brain carboxylesterase , 1999, FEBS letters.
[52] W. Junge,et al. Human liver carboxylesterase. Purification and molecular properties. , 1974, Archives of biochemistry and biophysics.
[53] Hans Lennernäs,et al. Comparison Between Permeability Coefficients in Rat and Human Jejunum , 1996, Pharmaceutical Research.
[54] Sompop Bencharit,et al. Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil. , 2005, Journal of molecular biology.
[55] J. Robert,et al. Determinants of the cytotoxicity of irinotecan in two human colorectal tumor cell lines , 2002, Cancer Chemotherapy and Pharmacology.
[56] G. Mulder,et al. Absorption and metabolism of acetaminophen by the in situ perfused rat small intestine preparation. , 1986, Drug metabolism and disposition: the biological fate of chemicals.
[57] H Lennernäs,et al. Human intestinal permeability. , 1998, Journal of pharmaceutical sciences.
[58] R. Remmel,et al. First-pass disposition of (-)-6-aminocarbovir in rats: II. Inhibition of intestinal first-pass metabolism. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[59] Y. Tsuda,et al. Mechanism of intestinal absorption of an orally active beta-lactam prodrug: uptake and transport of carindacillin in Caco-2 cells. , 1999, The Journal of pharmacology and experimental therapeutics.
[60] T. Imai,et al. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa. , 1998, Life sciences.
[61] Sara K Quinney,et al. Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino]-carbonyloxycamptothecin, by human carboxylesterases CES1A1, CES2, and a newly expressed carboxylesterase isoenzyme, CES3. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[62] E. Pennings,et al. Effects of concurrent use of alcohol and cocaine. , 2002, Addiction.
[63] K Hirano,et al. Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver. , 1997, Biological & pharmaceutical bulletin.
[64] Matthew R. Redinbo,et al. Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme , 2003, Nature Structural Biology.
[65] Kristina Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1 , 2001 .
[66] H. McLeod,et al. Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[67] M Hosokawa,et al. The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.
[68] M. Redinbo,et al. Stereoselective hydrolysis of pyrethroid-like fluorescent substrates by human and other mammalian liver carboxylesterases. , 2005, Chemical research in toxicology.
[69] J. Cashman,et al. Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[70] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport , 1996 .
[71] M. Tsuboi,et al. Comparative study of human intestinal and hepatic esterases as related to enzymatic properties and hydrolizing activity for ester-type drugs. , 1980, Japanese journal of pharmacology.
[72] T. Imai,et al. FIRST-PASS HYDROLYSIS OF A PROPRANOLOL ESTER DERIVATIVE IN RAT SMALL INTESTINE , 2006, Drug Metabolism and Disposition.
[73] M. Kasuga,et al. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. , 2002, Drug metabolism and disposition: the biological fate of chemicals.